Why tirzepatide might be better than retatrutide for women in menopause
Health Coach Kait (Kait Malthaner) — Why tirzepatide might be better than retatrutide for women in menopause
Channel: Kait Malthaner (BSc Nutrition & Exercise) · Our label: Nutrition & exercise coach · Source: youtube.com/watch?v=TNlVKRFgfww
What this video covers
Verat true is getting a lot of attention right now and with good reason. The early trial data showing over 20% body weight reduction is genuinely impressive better than we’ve seen from any other GLP-1 so far. But I want to make a case today on why reatride isn’t necessarily the best option for all women who want to lose weight and specifically why for women who are in pmenopause or menopause tratide might be a better tool. Now this isn’t about one being better than the other in absolute terms.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- The early trial data showing over 20% body weight reduction is genuinely impressive better than we’ve seen from any other GLP-1 so far.
- I’ve covered both of these peptides extensively on my channel and I’ve tried both.
- I’ll link to my full peptide playlist up above if you want to know more about my personal experience.
- There’s also emerging data on GLP-1 and GIP effects on bone density, which is relevant for post-menopausal women given the increased fracture risk that comes with estrogen decline.
- Trisepatide has a well-established side effect profile from these trials.
- So, if you’re getting some of these side effects on GLP1s, if you’re getting dizzy, if you’re getting headaches, if you’re constantly fatigued, it might just be an electrolyte issue.
Read next
- GLP-1 class — more videos
- Tirzepatide — more videos
- Retatrutide — more videos
- All videos from this channel
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.